Jurgen M Lehmann

Title: Jurgen M Lehmann: Innovator in Gene Modulation

Introduction

Jurgen M Lehmann is a notable inventor based in Solana Beach, CA (US). He has made significant contributions to the field of gene modulation, holding a total of 3 patents. His work focuses on the development of novel compounds and methods that have potential applications in pharmaceuticals and gene expression.

Latest Patents

Lehmann's latest patents include innovative compounds known as bridged bicyclic aromatic compounds. These compounds are designed to modulate gene expression of retinoic acid receptors, vitamin D receptors, and thyroid receptors. Additionally, he has developed methods for screening substances that affect the formation of retinoid X receptor homodimers. His inventions also encompass methods for inhibiting the activity of retinoid X receptor heterodimers and determining the probability of pathologies associated with these receptors.

Career Highlights

Throughout his career, Jurgen M Lehmann has worked with esteemed organizations such as the La Jolla Cancer Research Foundation and SRI International. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Peter D Hobbs, with whom he has worked on various projects related to gene modulation and receptor activity.

Conclusion

Jurgen M Lehmann's innovative work in gene modulation and his contributions to the scientific community highlight his role as a significant inventor in this field. His patents and collaborations continue to pave the way for advancements in pharmaceutical applications and gene expression modulation.